TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Barnekreftforeningen
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
397
|
5,532
|
4,514 |
| Financial expenses |
3
|
1
|
0 |
| Earnings before taxes |
31,217
|
2,265
|
680 |
| Total assets |
45,827
|
14,106
|
12,766 |
| Current assets |
44,926
|
13,149
|
11,733 |
| Current liabilities |
6,859
|
499
|
910 |
| Equity capital |
38,968
|
8,169
|
6,304 |
| - share capital |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
85.0%
|
57.9%
|
49.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7863.2%
|
40.9%
|
15.1% |
| Return on assets (ROA) |
68.1%
|
16.1%
|
5.3% |
| Current ratio |
655.0%
|
2635.1%
|
1289.3% |
| Return on equity (ROE) |
80.1%
|
27.7%
|
10.8% |
| Change turnover |
-4,852
|
1,305
|
-460 |
| Change turnover % |
-92%
|
31%
|
-9% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.